APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $65.5M invested in Aptevo Therapeutics in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.22M
2
+$781K
3
+$508K

Top Sellers

1
-$1.53M
2
-$1.21M
3
-$1.18M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$928K
5
Renaissance Technologies
Renaissance Technologies
New York
-$717K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
1
2